0

Cyclothiazide

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP2259963-A
CAS2259-96-3
Structure
MDL NumberMFCD00210192
Molecular Weight389.88
InChI KeyBOCUKUHCLICSIY-QJWLJZLASA-N
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Size200MG
1

Allosteric Interactions Between Cyclothiazide and AMPA/kainate Receptor Antagonists

K A Yamada, D M Turetsky

Br J Pharmacol. 1996 Apr;117(8):1663-72.

PMID: 8732274

1

Auxiliary Subunits of the CKAMP Family Differentially Modulate AMPA Receptor Properties

Paul Farrow, Konstantin Khodosevich, Yechiam Sapir, Anton Schulmann, Muhammad Aslam, Yael Stern-Bach, Hannah Monyer, Jakob von Engelhardt

Elife. 2015 Dec 1;4:e09693.

PMID: 26623514

1

Effect of Cyclothiazide on Binding Properties of AMPA-type Glutamate Receptors: Lack of Competition Between Cyclothiazide and GYKI 52466

M Kessler, A Arai, A Quan, G Lynch

Mol Pharmacol. 1996 Jan;49(1):123-31.

PMID: 8569697

1

Interactions Among GYKI-52466, Cyclothiazide, and Aniracetam at Recombinant AMPA and Kainate Receptors

T H Johansen, A Chaudhary, T A Verdoorn

Mol Pharmacol. 1995 Nov;48(5):946-55.

PMID: 7476926

1

Neuronal TDP-43 Depletion Affects Activity-Dependent Plasticity

Paulina Koza, Anna Beroun, Anna Konopka, Tomasz Górkiewicz, Lukasz Bijoch, Julio C Torres, Ewa Bulska, Ewelina Knapska, Leszek Kaczmarek, Witold Konopka

Neurobiol Dis. 2019 Oct;130:104499.

PMID: 31176717

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode